Key September 2025 updates on U.S. healthcare funding, CDC leadership changes, AI in healthcare, Medicare and Medicaid policies, and COVID-19 vaccine authorization shifts impacting insurers and providers.

Discover how AI-driven tools like Counterforce Health empower patients and providers to effectively counter health insurance claim denials and navigate prior authorization challenges.

Explore how AI integration in U.S. insurance companies is boosting operational efficiency, premium growth, and dividends for investors.

Swiss Re spotlights nuclear energy expansion and escalating civil unrest risks at RVS 2025, underscoring reinsurance's role in managing geopolitical volatility and emerging underwriting challenges.

CMS to start AI-driven prior authorization pilot for traditional Medicare in Washington and five other states in 2026, targeting low-value procedures to reduce waste and improve compliance while maintaining clinician oversight.

Medicare initiates an AI-based pilot program to aid in approving or denying certain medical procedures, raising considerations about healthcare administrative processes and payer-provider dynamics.

Baker Tilly partnered with a mutual P&C insurer to validate compliance with the NAIC Model AI Bulletin and benchmark AI governance maturity, delivering a strategic roadmap for responsible AI adoption in insurance.

Explore how the aging U.S. population is fueling AI healthcare innovation, annuity growth, and healthspan technologies, creating new investment opportunities in longevity markets.

Explore how P&C insurers are leveraging cloud-based data architectures and AI to enhance underwriting accuracy, claims efficiency, and regulatory compliance in a rapidly evolving market.

Explore July 2025's largest U.S. funding rounds featuring fintech, insurtech, and AI startups. Key investments highlight trends in commercial auto insurance, financial operations, and innovative tech platforms.